Showing results (2581-2590 of 2,949) with videos related to

Sort By:
Pageof 295
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Methodological issues in primary prevention trials for neurodegenerative dementiaSandrine Andrieu, Nicola Coley, Paul Aisen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2004
Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemiaHans-Peter Kiem, Stephanie Sellers, Bobbie Thomasson, et al.
Neurobiology of Aging|May 11, 2010
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide studyPatricia L Kramer, Haiyan Xu, Randall L Woltjer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseGuy M McKhann, David S Knopman, Howard Chertkow, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Enolase inhibitors as therapeutic leads for Naegleria fowleri infectionJillian E Milanes, Victoria C Yan, Cong-Dat Pham, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
Elife|January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational studyPeter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Bone Marrow Transplantation|March 24, 2015
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myelomaF Sahebi, S Iacobelli, A V Biezen, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma bruceiColm P Roster, Danielle LaVigne, Jillian E Milanes, et al.
Pageof 295